{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,20]],"date-time":"2026-11-20T07:59:40Z","timestamp":1795161580838,"version":"4.10.3"},"reference-count":33,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,12]]},"abstract":"<jats:sec>\n            <jats:title>Background and Aims:<\/jats:title>\n            <jats:p>Dyskeratosis congenita (DC) and related telomere biology disorders (TBD) are characterized by very short telomeres and multisystem organ involvement including liver disease. Our study aimed to characterize baseline hepatic abnormalities in patients with DC\/TBD and determine risk factors associated with liver disease progression.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Approach and Results:<\/jats:title>\n            <jats:p>A retrospective review was performed on a cohort of 58 patients (39 males) with DC\/TBD who were prospectively evaluated at a single institute from 2002 to 2019. The median age at initial assessment was 18 (1.4\u201367.6) years, and median follow-up duration was 6 (1.4\u20138.2) years. Patients with autosomal or X-linked recessive inheritance and those with heterozygous <jats:italic toggle=\"yes\">TINF2<\/jats:italic> DC were significantly younger, predominantly male, and more likely to have DC-associated mucocutaneous triad features and severe bone marrow failure compared with autosomal dominant-non-<jats:italic toggle=\"yes\">TINF2<\/jats:italic> DC\/TBD patients. Liver abnormality (defined at baseline assessment by laboratory and\/or radiological findings) was present in 72.4% of patients with predominantly cholestatic pattern of liver enzyme elevation. Clinically significant liver disease and portal hypertension developed in 17.2% of patients during the 6-year follow-up; this progression was mainly seen in patients with recessive or <jats:italic toggle=\"yes\">TINF2<\/jats:italic>-associated DC. Significant risk factors associated with progression included the presence of pulmonary or vascular disease.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>Our experience shows a high prevalence of cholestatic pattern of liver abnormality with progression to portal hypertension in patients with DC\/TBD. Presence of pulmonary and\/or vascular disease in patients with recessive or <jats:italic toggle=\"yes\">TINF2<\/jats:italic> DC was an important predictor of liver disease progression, suggesting the need for increased vigilance and monitoring for complications in these patients.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/hep.0000000000000461","type":"journal-article","created":{"date-parts":[[2023,5,15]],"date-time":"2023-05-15T09:01:26Z","timestamp":1684141286000},"page":"1777-1787","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":22,"title":["Progression of liver disease and portal hypertension in dyskeratosis congenita and related telomere biology disorders"],"prefix":"10.1097","volume":"78","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3855-5023","authenticated-orcid":false,"given":"Anusha","family":"Vittal","sequence":"first","affiliation":[{"name":"Liver Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9565-5565","authenticated-orcid":false,"given":"Marena R.","family":"Niewisch","sequence":"additional","affiliation":[{"name":"Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"Bhala","sequence":"additional","affiliation":[{"name":"Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pujitha","family":"Kudaravalli","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, SUNY Upstate Medical University, Syracuse, New York, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farial","family":"Rahman","sequence":"additional","affiliation":[{"name":"Liver Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7608-0914","authenticated-orcid":false,"given":"Julian","family":"Hercun","sequence":"additional","affiliation":[{"name":"Liver Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David E.","family":"Kleiner","sequence":"additional","affiliation":[{"name":"Laboratory of Pathology, National Cancer Institute, Bethesda, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6006-0740","authenticated-orcid":false,"given":"Sharon A.","family":"Savage","sequence":"additional","affiliation":[{"name":"Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4755-5607","authenticated-orcid":false,"given":"Christopher","family":"Koh","sequence":"additional","affiliation":[{"name":"Liver Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theo","family":"Heller","sequence":"additional","affiliation":[{"name":"Liver Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7353-1863","authenticated-orcid":false,"given":"Neelam","family":"Giri","sequence":"additional","affiliation":[{"name":"Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2023,5,16]]},"reference":[{"key":"R1-20250824","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1080\/17474086.2022.2108784","article-title":"The biology and management of dyskeratosis congenita and related disorders of telomeres","volume":"15","author":"Tummala","year":"2022","journal-title":"Expert review of hematology"},{"key":"R2-20250824","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1080\/17474086.2019.1662720","article-title":"An update on the biology and management of dyskeratosis congenita and related telomere biology disorders","volume":"12","author":"Niewisch","year":"2019","journal-title":"Expert review of hematology"},{"key":"R3-20250824","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1101\/gad.326785.119","article-title":"ZCCHC8, the nuclear exosome targeting component, is mutated in familial pulmonary fibrosis and is required for telomerase RNA maturation","volume":"33","author":"Gable","year":"2019","journal-title":"Genes Dev"},{"key":"R4-20250824","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/j.jaad.2017.10.017","article-title":"Beyond the triad: Inheritance, mucocutaneous phenotype, and mortality in a cohort of patients with dyskeratosis congenita","volume":"78","author":"Ward","year":"2018","journal-title":"J Am Acad Dermatol"},{"key":"R5-20250824","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1016\/S0140-6736(03)14797-6","article-title":"Late presentation of dyskeratosis congenita as apparently acquired aplastic anaemia due to mutations in telomerase RNA","volume":"362","author":"Fogarty","year":"2003","journal-title":"Lancet"},{"key":"R6-20250824","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1038\/ng.3278","article-title":"Exome sequencing links mutations in PARN and RTEL1 with familial pulmonary fibrosis and telomere shortening","volume":"47","author":"Stuart","year":"2015","journal-title":"Nature Genetics"},{"key":"R7-20250824","doi-asserted-by":"crossref","first-page":"e7926","DOI":"10.1371\/journal.pone.0007926","article-title":"A spectrum of severe familial liver disorders associate with telomerase mutations","volume":"4","author":"Calado","year":"2009","journal-title":"PLoS One"},{"key":"R8-20250824","doi-asserted-by":"crossref","first-page":"e293","DOI":"10.3324\/haematol.2017.167056","article-title":"Myelodysplasia and liver disease extend the spectrum of RTEL1 related telomeropathies","volume":"102","author":"Cardoso","year":"2017","journal-title":"Haematologica"},{"key":"R9-20250824","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1038\/ng1346","article-title":"Disease anticipation is associated with progressive telomere shortening in families with dyskeratosis congenita due to mutations in TERC","volume":"36","author":"Vulliamy","year":"2004","journal-title":"Nat Genet"},{"key":"R10-20250824","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1182\/blood.2021013523","article-title":"Disease progression and clinical outcomes in telomere biology disorders","volume":"139","author":"Niewisch","year":"2022","journal-title":"Blood"},{"key":"R11-20250824","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1046\/j.1365-2141.2000.02109.x","article-title":"Dyskeratosis congenita in all its forms","volume":"110","author":"Dokal","year":"2000","journal-title":"Br J Haematol"},{"key":"R12-20250824","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1378\/chest.15-0825","article-title":"Hepatopulmonary syndrome is a frequent cause of dyspnea in the short telomere disorders","volume":"148","author":"Gorgy","year":"2015","journal-title":"Chest"},{"key":"R13-20250824","doi-asserted-by":"crossref","first-page":"2579","DOI":"10.1002\/hep.30578","article-title":"The spectrum of hepatic involvement in patients with telomere disease","volume":"69","author":"Kapuria","year":"2019","journal-title":"Hepatology"},{"key":"R14-20250824","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1002\/hep.24173","article-title":"Constitutional telomerase mutations are genetic risk factors for cirrhosis","volume":"53","author":"Calado","year":"2011","journal-title":"Hepatology"},{"key":"R15-20250824","doi-asserted-by":"crossref","first-page":"e13695","DOI":"10.1111\/petr.13695","article-title":"Successful liver transplantation in short telomere syndromes without bone marrow failure due to DKC1 mutation","volume":"24","author":"Del Brio Castillo","year":"2020","journal-title":"Pediatr Transplant"},{"key":"R16-20250824","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1002\/hep.31111","article-title":"Liver transplantation for decompensated cirrhosis secondary to telomerase reverse transcriptase mutation","volume":"72","author":"Kolb","year":"2020","journal-title":"Hepatology"},{"key":"R17-20250824","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1097\/TP.0000000000002198","article-title":"Multiple solid organ transplantation in telomeropathy: Case series and literature review","volume":"102","author":"Lebeer","year":"2018","journal-title":"Transplantation"},{"key":"R18-20250824","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1002\/lt.25734","article-title":"Combined lung and liver transplantation for short telomere syndrome","volume":"26","author":"Moschouri","year":"2020","journal-title":"Liver Transpl"},{"key":"R19-20250824","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s10456-018-9640-7","article-title":"Understanding the evolving phenotype of vascular complications in telomere biology disorders","volume":"22","author":"Higgs","year":"2019","journal-title":"Angiogenesis"},{"key":"R20-20250824","doi-asserted-by":"crossref","first-page":"2652","DOI":"10.1002\/hep.30557","article-title":"Telomerase variants in patients with cirrhosis awaiting liver transplantation","volume":"69","author":"Chiu","year":"2019","journal-title":"Hepatology"},{"key":"R21-20250824","doi-asserted-by":"crossref","first-page":"30","DOI":"10.3324\/haematol.2017.178111","article-title":"Cancer in the National Cancer Institute inherited bone marrow failure syndrome cohort after fifteen years of follow-up","volume":"103","author":"Alter","year":"2018","journal-title":"Haematologica"},{"key":"R22-20250824","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/ajg.2016.517","article-title":"ACG Clinical Guideline: Evaluation of Abnormal Liver Chemistries","volume":"112","author":"Kwo","year":"2017","journal-title":"Am J Gastroenterol"},{"key":"R23-20250824","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/0168-8278(95)80226-6","article-title":"Histological grading and staging of chronic hepatitis","volume":"22","author":"Ishak","year":"1995","journal-title":"J Hepatol"},{"key":"R24-20250824","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1053\/j.seminhematol.2006.04.001","article-title":"Dyskeratosis congenita","volume":"43","author":"Vulliamy","year":"2006","journal-title":"Semin Hematol"},{"key":"R25-20250824","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1182\/blood-2007-02-075598","article-title":"Very short telomere length by flow fluorescence in situ hybridization identifies patients with dyskeratosis congenita","volume":"110","author":"Alter","year":"2007","journal-title":"Blood"},{"key":"R26-20250824","doi-asserted-by":"crossref","first-page":"353","DOI":"10.3324\/haematol.2011.055269","article-title":"Telomere length is associated with disease severity and declines with age in dyskeratosis congenita","volume":"97","author":"Alter","year":"2012","journal-title":"Haematologica"},{"key":"R27-20250824","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1038\/ajg.2014.131","article-title":"ACG Clinical Guideline: the diagnosis and management of idiosyncratic drug-induced liver injury","volume":"109","author":"Chalasani","year":"2014","journal-title":"Am J Gastroenterol"},{"key":"R28-20250824","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1212\/NXG.0000000000000370","article-title":"CNS manifestations in patients with telomere biology disorders","volume":"5","author":"Bhala","year":"2019","journal-title":"Neurol Genet"},{"key":"R29-20250824","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1002\/hep.24217","article-title":"Telomerase gene mutations are associated with cirrhosis formation","volume":"53","author":"Hartmann","year":"2011","journal-title":"Hepatology"},{"key":"R30-20250824","doi-asserted-by":"crossref","first-page":"702","DOI":"10.6002\/ect.2020.0073","article-title":"Liver transplant for management of hepatic complications of dyskeratosis congenita: A case report","volume":"20","author":"Alebrahim","year":"2022","journal-title":"Exp Clin Transplant"},{"key":"R31-20250824","doi-asserted-by":"crossref","first-page":"e13802","DOI":"10.1111\/petr.13802","article-title":"Combined lung and liver transplantation for noncirrhotic portal hypertension with severe hepatopulmonary syndrome in a patient with dyskeratosis congenita","volume":"25","author":"Shin","year":"2021","journal-title":"Pediatric Transplantation"},{"key":"R32-20250824","doi-asserted-by":"crossref","first-page":"312","DOI":"10.4103\/0019-5049.156888","article-title":"Dyskeratosis congenita induced cirrhosis for liver transplantation-perioperative management","volume":"59","author":"Singh","year":"2015","journal-title":"Indian J Anaesth"},{"key":"R33-20250824","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.jceh.2015.10.003","article-title":"Liver transplantation after bone marrow transplantation for end stage liver disease with severe hepatopulmonary syndrome in dyskeratosis congenita: a literature first","volume":"5","author":"Mahansaria","year":"2015","journal-title":"J Clin Exp Hepatol"}],"container-title":["Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/HEP.0000000000000461","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,24]],"date-time":"2025-08-24T22:06:12Z","timestamp":1756073172000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/HEP.0000000000000461"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,16]]},"references-count":33,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/hep.0000000000000461","relation":{},"ISSN":["0270-9139"],"issn-type":[{"value":"0270-9139","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5,16]]},"assertion":[{"value":"2023-01-17","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-04-28","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}